Wealth Quarterback’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Buy
+7,642
New +$203K 0.08% 154
2024
Q4
Sell
-15,954
Closed -$462K 132
2024
Q3
$462K Sell
15,954
-1,903
-11% -$55.5K 0.24% 76
2024
Q2
$500K Buy
17,857
+189
+1% +$5.2K 0.28% 66
2024
Q1
$490K Buy
17,668
+3,992
+29% +$111K 0.27% 76
2023
Q4
$394K Buy
13,676
+1,809
+15% +$54.7K 0.24% 82
2023
Q3
$394K Buy
11,867
+1,879
+19% +$66.4K 0.34% 73
2023
Q2
$366K Buy
9,988
+576
+6% +$22.4K 0.25% 78
2023
Q1
$384K Sell
9,412
-374
-4% -$16.2K 0.33% 70
2022
Q4
$501K Sell
9,786
-74
-0.8% -$3.55K 0.42% 56
2022
Q3
$431K Sell
9,860
-409
-4% -$19.9K 0.46% 54
2022
Q2
$538K Buy
+10,269
New +$523K 0.42% 50
2021
Q3
$455K Buy
12,686
+1,901
+18% +$84.2K 0.3% 69
2021
Q2
$423K Buy
+10,785
New +$419K 0.26% 76
2020
Q4
$397K Sell
10,784
-993
-8% -$36.4K 0.33% 71
2020
Q3
$365K Hold
11,777
0.33% 74
2020
Q2
$365K Buy
11,777
+1,772
+18% +$60.2K 0.33% 74
2020
Q1
$303K Sell
10,005
-5,254
-34% -$179K 0.28% 77
2019
Q4
$472K Buy
+15,259
New +$544K 0.41% 55

Other funds holding PFE

Wealth Quarterback's PFE Position: Q1 2026 in Review

Wealth Quarterback opened a new position in Pfizer (PFE) in Q1 2026: 7,642 shares worth $215K. The stake represents 0.08% of the portfolio and ranks #154 among its holdings. This is a return to the name: Wealth Quarterback previously reported a position in PFE as recently as Q3 2024.

Wealth Quarterback first reported a position in PFE in Q4 2019 and has held it in 18 quarters since. The position peaked at $538K in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wealth Quarterback held 7,642 shares of Pfizer worth $215K as of Q1 2026.
  • Pfizer was a new Wealth Quarterback position in Q1 2026.
  • Pfizer made up 0.08% of Wealth Quarterback's portfolio in Q1 2026, its #154 holding.
  • Wealth Quarterback first reported a position in Pfizer in Q4 2019 and has held it in 18 quarters since.
  • Wealth Quarterback's Pfizer position peaked at $538K in Q2 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wealth Quarterback's 13F filing for Q1 2026, filed 9 Apr 2026.